AccuStem Sciences Inc. announced the formation of its executive leadership team as the first major step toward commercializing new products in the oncology space. Wendy Blosser, a commercial executive with extensive leadership experience at diagnostic companies in the oncology sector, has been named Chief Executive Officer for the comapny. Wendy most recently served as the Chief Commercial Officer for Agendia, a leading breast oncology company, where she led the organization to its highest sales volume and revenue since its inception.

Prior to that, Wendy served as the Chief Commercial Officer at Biodesix where she oversaw the launch and rapid growth of its blood-based genomic testing, GeneStrat.